Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 1/2 × Has announcements × EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Neoplasms 7 Colonic Neoplasms 5 Thyroid Neoplasms 4 Thyroid Diseases 4 Thyroid Cancer, Papillary 4 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 4 Respiratory Tract Diseases 4 Neoplasms by Site 4 Lung Neoplasms 4 Lung Diseases 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Endocrine System Diseases 4 Endocrine Gland Neoplasms 4 Carcinoma, Bronchogenic 4 Bronchial Neoplasms 4 Sarcoma 3 Recurrence 3 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hematologic Neoplasms 3 Central Nervous System Neoplasms 3 Carcinoma, Medullary 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡